PreludeDx Strengthens Executive Leadership with MiMi Reyes
Prelude Corporation, known as PreludeDx, a leader in precision diagnostics focused on early-stage breast cancer, has recently welcomed MiMi Reyes to its executive management team. Reyes will serve as the Senior Vice President of Operations, bringing with her over 25 years of valuable experience in the diagnostics and medical device industry. This strategic hiring comes at a crucial time for PreludeDx as the company is set to enhance its operational framework to accommodate growing demand for innovative diagnostic solutions.
MiMi Reyes: A Veteran in Diagnostics and Operations
Reyes shares her excitement about joining the company during this pivotal phase. She acknowledges the solid groundwork that PreludeDx has established in the sphere of precision diagnostics and expresses her eagerness to collaborate with diverse teams. Her focus will be on enhancing operational efficiencies, fostering innovation, and ensuring high-quality testing that meaningfully affects patient outcomes.
Reyes is recognized for her results-driven approach and her knack for driving growth in regulated environments. Her background encompasses directing global molecular operations while effectively managing laboratories that comply with CAP, CLIA, FDA, ISO 9001, and ISO 13485 standards. This expertise positions her as a key player in building high-performing teams and optimizing operational processes.
Experience Brings Depth to PreludeDx
Before her role at PreludeDx, Reyes held a prominent position within the Executive Management team at MDxHealth. There, she guided Global Operations and spearheaded diagnostic testing initiatives in various areas, including prostate cancer, bladder cancer, and urinary tract infections.
Throughout her career, Reyes has made significant contributions, notably being an early pioneer at Agendia, where she was instrumental in the launch of the MammaPrint test, designed for early-stage breast cancer assessment. Her history also includes leadership roles at CombiMatrix and US LABS, showcasing her broad experience in laboratory management and diagnostics.
Dan Forche, President and CEO of PreludeDx, lauds Reyes's operational leadership qualities, her comprehension of the intricacies of regulated diagnostics, and her ability to build scalable laboratory operations. He states that her extensive experience will be vital as PreludeDx gears up to meet increased patient demand with exciting new projects, including their forthcoming AidaBreast invasive breast cancer test.
Educational Background of MiMi Reyes
Reyes holds a Bachelor of Science degree in Biology from the University of California, Irvine, and an Executive Healthcare MBA from the Paul Merage School of Business at the same university. This academic background complements her extensive professional experience and positions her well to lead PreludeDx's operational initiatives.
About PreludeDx
PreludeDx is a pioneering personalized breast cancer diagnostics company dedicated to enhancing patient care and informing treatment decisions. Founded in 2009 with technology stemming from innovative research at the University of California San Francisco, PreludeDx is committed to developing cutting-edge breast cancer diagnostic tools. Their mission focuses on improving patient outcomes and minimizing healthcare costs. PreludeDx emphasizes awareness through initiatives such as Know Your Risk™ and Know Your Benefit, encouraging informed decisions regarding treatment options.
Connect with PreludeDx
For those seeking more information about how PreludeDx is making strides in breast cancer diagnostics and impacting patient lives, it is encouraged to explore their official website. Stay connected and follow their journey on social media platforms like X, LinkedIn, Instagram, and Facebook for the latest updates.
Frequently Asked Questions
Who is MiMi Reyes and what is her new role at PreludeDx?
MiMi Reyes has been appointed as the Senior Vice President of Operations at PreludeDx, focused on enhancing operational capacities in diagnostics.
What experience does MiMi Reyes bring to PreludeDx?
MiMi Reyes brings over 25 years of experience in the diagnostics and medical device industries, having held leadership positions in various organizations.
What are PreludeDx's primary areas of focus?
PreludeDx specializes in precision diagnostics for breast cancer, aiming to improve patient outcomes and treatment strategies through innovative technology.
Why is MiMi Reyes's appointment significant for PreludeDx?
Her vast experience in operational leadership will support PreludeDx's initiatives to scale laboratory operations and respond to increased patient demand.
How can the public learn more about PreludeDx's advancements?
Interested individuals can explore PreludeDx's website for further insights and follow their social media channels for updates on their developments and impact.
